Search research articles
Contact Us
Filters
Showing results (181-190 of 191) with videos related to
Page
of 20
Sort By:
Leukemia Research
|
June 30, 2015
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes
G Caocci, M T Voso, E Angelucci, et al.
Genomics
|
June 15, 1997
Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia
S Kalachikov, A Migliazza, E Cayanis, et al.
Blood Cancer Journal
|
November 10, 2018
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials
A Castellino, A Chiappella, B R LaPlant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 25, 2018
Genetic landscape of ultra-stable chronic lymphocytic leukemia patients
S Raponi, I Del Giudice, M Marinelli, et al.
Annals of Hematology
|
August 21, 2013
Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study)
M Mian, D Capello, M B Ventre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 23, 2011
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion
M Mian, M Scandurra, E Chigrinova, et al.
Leukemia
|
April 27, 2016
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists
V De Stefano, M Ruggeri, F Cervantes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2023
Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial
M Ladetto, R Tavarozzi, M Zanni, et al.
Blood Cancer Journal
|
November 5, 2016
Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients
V De Stefano, A M Vannucchi, M Ruggeri, et al.
Leukemia
|
June 20, 2014
Recurrent mutations refine prognosis in chronic lymphocytic leukemia
P Baliakas, A Hadzidimitriou, L-A Sutton, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 191) with videos related to
Sort By:
Page
of 20
Leukemia Research
|
June 30, 2015
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes
G Caocci, M T Voso, E Angelucci, et al.
Genomics
|
June 15, 1997
Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia
S Kalachikov, A Migliazza, E Cayanis, et al.
Blood Cancer Journal
|
November 10, 2018
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials
A Castellino, A Chiappella, B R LaPlant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 25, 2018
Genetic landscape of ultra-stable chronic lymphocytic leukemia patients
S Raponi, I Del Giudice, M Marinelli, et al.
Annals of Hematology
|
August 21, 2013
Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study)
M Mian, D Capello, M B Ventre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 23, 2011
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion
M Mian, M Scandurra, E Chigrinova, et al.
Leukemia
|
April 27, 2016
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists
V De Stefano, M Ruggeri, F Cervantes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2023
Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial
M Ladetto, R Tavarozzi, M Zanni, et al.
Blood Cancer Journal
|
November 5, 2016
Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients
V De Stefano, A M Vannucchi, M Ruggeri, et al.
Leukemia
|
June 20, 2014
Recurrent mutations refine prognosis in chronic lymphocytic leukemia
P Baliakas, A Hadzidimitriou, L-A Sutton, et al.
Page
of 20